Dana Investment Advisors, Inc.

Position in ALKS — Alkermes plc.

CIK 1427514 BROOKFIELD, WI

Position in ALKS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,043,180

+$615,768 QoQ

Shares Held

38,992

-3.4% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#177

of 423 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $41,564,859 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PAHC	Phibro Animal Health Corp	387,867	$12,179,023
2	ANIP	Ani Pharmaceuticals Inc	109,942	$9,100,998
3	ELAN	Elanco Animal Health Inc	310,768	$7,648,000
4	NBIX	Neurocrine Biosciences Inc	36,763	$6,196,036
5	PBH	Prestige Consumer Healthcare Inc.	93,032	$4,397,622
6	ALKS	Alkermes plc. This page	38,992	$2,043,180

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,043,180	38,992	-3.4%	Shares	Sole	2026-08-13
2026-03-31	$1,427,412	40,368	+2.3%	Shares	Sole	2026-05-14
2025-12-31	$1,103,978	39,456	+44.3%	Shares	Sole	2026-02-05
2025-09-30	$820,020	27,334	+19.0%	Shares	Sole	2025-11-10
2025-06-30	$657,143	22,969	-1.3%	Shares	Sole	2025-08-13
2025-03-31	$768,573	23,276	-18.5%	Shares	Sole	2025-05-15
2024-12-31	$821,673	28,570	-0.1%	Shares	Sole	2025-02-06
2024-09-30	$800,290	28,592	+2.2%	Shares	Sole	2024-11-13
2024-06-30	$674,028	27,968	+47.0%	Shares	Sole	2024-08-27
2024-03-31	$515,087	19,028	+6.2%	Shares	Sole	2024-05-15
2023-12-31	$496,795	17,909	+78.4%	Shares	Sole	2024-02-07
2023-09-30	$281,164	10,038	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.